Skip to content

An open label double arm randomised controlled clinical study of Nonganadi ghrita orally on normal delivery

An Open Label Double Arm Randomised Controlled Clinical Study Of Nonganadi Ghrita on Prasava - NG

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070330
Enrollment
30
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery Health Condition 2: 1- Obstetrics

Interventions

None listed

Sponsors

Dr Shweta Balamkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women willing for trial Patients fulfilling the criteria of full term(36 weeks) Age-21 to 35 years Primi gravida Cephalic presentation

Exclusion criteria

Exclusion criteria: Previous LSCS HIV, HBsAg, VDRL reactive subjects Absolute indication of cesarean section such as- central placenta previa, contracted pelvis or cephalo-pelvic disproportion, pelvic mass, advanced carcinoma cervix and vaginal obstruction. Any systemic disorders like hypertension, diabetes etc.

Design outcomes

Primary

MeasureTime frame
Favourable changes in the Bishops score Decrease in duration of three stages of laborTimepoint: 0day-30days

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Shweta Balamkar

SDM Institute of Ayurveda and Hospital, Anchepalya, Bangalore, Karnataka, 560074, India

Padmasarithareddy@gmail.com7353254151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026